Document Detail


(18)F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
MedLine Citation:
PMID:  23337965     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: We investigated the relationship between overall survival of patients and pretreatment [(18)F]-2-fluorodeoxyglucose ((18)F-FDG) uptake, assessed by positron emission tomography combined with computed tomography (PET/CT) in hypopharyngeal squamous cell carcinoma. METHODS: Thirty-one patients who were newly diagnosed as resectable hypopharyngeal squamous cell carcinoma underwent pretreatment (18)F-FDG-PET/CT. We used the maximum standardized uptake value (SUVmax) as (18)F-FDG uptake. Overall survival rate was calculated by the Kaplan-Meier method. RESULTS: The median SUVmax was 11.53 (range 2.49-22.33). Patients with SUVmax ≥ 13 significantly exhibited shorter overall survival in univariate analysis (p < 0.01). Moreover, by Cox proportional hazards model of multivariate analysis, SUVmax ≥ 13 was a significant prognostic factor independent of clinical T and N classification, and treatment group (p < 0.02). CONCLUSIONS: These results suggested that SUVmax obtained by pretreatment (18)F-FDG PET/CT assessment is an important prognostic factor in patients with hypopharyngeal squamous cell carcinoma.
Authors:
Hidenori Suzuki; Katsuhiko Kato; Yasushi Fujimoto; Yoshiyuki Itoh; Mariko Hiramatsu; Takashi Maruo; Shinji Naganawa; Yasuhisa Hasegawa; Tsutomu Nakashima
Related Documents :
25009165 - Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors o...
24477605 - Increased serum level of epidermal growth factor receptor (egfr) is associated with poo...
1586505 - Postoperative radiotherapy of squamous cell carcinoma of the tonsil. factors influencin...
24994605 - Gstt1 and gstm1 polymorphisms predict treatment outcome for acute myeloid leukemia: a s...
22840785 - Overcoming resistance to egfr inhibitor in head and neck cancer: a review of the litera...
12075705 - Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Annals of nuclear medicine     Volume:  -     ISSN:  1864-6433     ISO Abbreviation:  Ann Nucl Med     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8913398     Medline TA:  Ann Nucl Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Head and Neck Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan, hi.suzuki@aichi-cc.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Antiinflammatory potential of seven plant extracts in the ultraviolet erythema test : A randomized...
Next Document:  Biological evaluation of 3-[(18)F]fluoro-?-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid t...